Betta Pharmaceuticals Co Ltd
300558
Company Profile
Business description
Betta Pharmaceuticals Co Ltd is a pharmaceutical enterprise that focuses on the research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates in China.
Contact
No. 355, Xingzhong Road
Economic and Technological Development Zone
Yuhang District, Zhejiang Province
Hangzhou311100
CHNT: +86 57189265665
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,936
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,832.30 | 81.60 | -1.03% |
| CAC 40 | 7,126.02 | 263.00 | 3.83% |
| DAX 40 | 20,562.73 | 891.85 | 4.53% |
| Dow JONES (US) | 39,577.49 | 1,030.96 | -2.54% |
| FTSE 100 | 7,913.25 | 233.77 | 3.04% |
| HKSE | 21,087.90 | 406.12 | 1.96% |
| NASDAQ | 16,387.31 | 737.66 | -4.31% |
| Nikkei 225 | 33,457.94 | 1,151.06 | -3.33% |
| NZX 50 Index | 12,019.13 | 182.30 | -1.49% |
| S&P 500 | 5,276.03 | 180.87 | -3.31% |
| S&P/ASX 200 | 7,625.10 | 84.50 | -1.10% |
| SSE Composite Index | 3,242.47 | 18.83 | 0.58% |